| Typicality: | 0.430 |
| Saliency: | 0.421 |
| on affects other industries | 9 | transitive-object |
| about the proposed drug complexes | 5 | other |
| to members | 3 | transitive-object |
| administration → provide → further information | 7 |
| administration → provide → more information | 7 |
| administration → provide → additional information | 5 |
| administration → provide → detail | 3 |
| administration → provide → more details | 3 |
| negative | neutral | positive |
| 0.109 | 0.800 | 0.091 |
| Raw frequency | 25 |
| Normalized frequency | 0.421 |
| Modifier score | 0.500 |
| Perplexity | 210.173 |